» Articles » PMID: 32356126

Evidence of Retinal Anterograde Neurodegeneration in the Very Early Stages of Multiple Sclerosis: a Longitudinal OCT Study

Abstract

Background: Neurodegenerative processes are present since the early stages of multiple sclerosis (MS), constituting the primary substrate of disability. As part of the CNS, retinal damage could be considered a reliable prognostic biomarker of neurodegeneration in MS.

Objectives: To characterize longitudinal changes in the retinal layers' thickness and to investigate correlations between retinal atrophy and other prognostic biomarkers, i.e., cerebrospinal fluid (CSF) β-amyloid (Aβ) levels.

Methods: Forty-two eyes without a history of optic neuritis of 23 MS patients were recruited. All patients underwent spectral-domain-OCT scans (SD-OCT), brain magnetic resonance imaging (MRI), and lumbar puncture at baseline. SD-OCT and brain MRI were repeated after 12 months. Ten controls underwent the same OCT procedure.

Results: At baseline, macular ganglion cell/inner plexiform layer (mGCIPL) thickness was reduced in patients compared to controls (p = 0.008), without retinal nerve fiber layer (RNFL) thinning, that was revealed only at follow-up (p = 0.005). Patients with lower CSF Aβ levels displayed reduced RNFL thickness values, both at baseline and follow-up.

Conclusions: At very early clinical stages, mGCIPL thickness values were reduced without a concomitant peripapillary RNFL thinning. The longitudinal assessment demonstrated a RNFL loss in patients compared to HC, together with a plateau of mGCIPL thinning. Aβ subgroup of patients showed a reduction of retinal nerve fiber layer thickness.

Citing Articles

New Method of Early RRMS Diagnosis Using OCT-Assessed Structural Retinal Data and Explainable Artificial Intelligence.

Ortiz M, Pueyo A, Dongil F, Boquete L, Sanchez-Morla E, Barea R Transl Vis Sci Technol. 2025; 14(2):14.

PMID: 39928305 PMC: 11812612. DOI: 10.1167/tvst.14.2.14.


Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis.

Mirmosayyeb O, Weinstock-Guttman B, Zivadinov R, Jakimovski D J Neurol. 2025; 272(2):141.

PMID: 39812862 DOI: 10.1007/s00415-024-12866-4.


Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography.

Lu S, Ma C, Du Y Open Life Sci. 2024; 19(1):20220866.

PMID: 38633413 PMC: 11022120. DOI: 10.1515/biol-2022-0866.


Optical coherence tomography with voxel-based morphometry: a new tool to unveil focal retinal neurodegeneration in multiple sclerosis.

Huang S, Pisa M, Guerrieri S, Dalla Costa G, Comi G, Leocani L Brain Commun. 2024; 6(1):fcad249.

PMID: 38328398 PMC: 10847824. DOI: 10.1093/braincomms/fcad249.


Regional Analysis of Inner Retinal Layer Changes in Multiple Sclerosis with and without Optic Neuritis.

Kayhan B, Sevincli S, Demir N, Demir S, Sonmez M Turk J Ophthalmol. 2023; 53(3):169-174.

PMID: 37345312 PMC: 10286840. DOI: 10.4274/tjo.galenos.2023.81486.


References
1.
Friese M, Schattling B, Fugger L . Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol. 2014; 10(4):225-38. DOI: 10.1038/nrneurol.2014.37. View

2.
Reich D, Lucchinetti C, Calabresi P . Multiple Sclerosis. N Engl J Med. 2018; 378(2):169-180. PMC: 6942519. DOI: 10.1056/NEJMra1401483. View

3.
Lassmann H . Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis. Front Immunol. 2019; 9:3116. PMC: 6335289. DOI: 10.3389/fimmu.2018.03116. View

4.
Bjartmar C, Trapp B . Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol. 2001; 14(3):271-8. DOI: 10.1097/00019052-200106000-00003. View

5.
Frischer J, Bramow S, Dal-Bianco A, Lucchinetti C, Rauschka H, Schmidbauer M . The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009; 132(Pt 5):1175-89. PMC: 2677799. DOI: 10.1093/brain/awp070. View